临床试验结果

HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium

Edward L Nelson

• 抽象的

临床试验结果

Oral iron therapies in development for iron deficiency in chronic kidney disease

David William Mudge & David Wayne Johnson

• 抽象的

临床试验方法

Outcome measures in amyotrophic lateral sclerosis clinical trials

Sabrina Paganoni, Merit Cudkowicz, James D Berry

• 抽象的

临床试验结果

Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders

Rupert Bauersachs

• 抽象的